Clene director granted 6,230 stock options
Clene Inc. director David J. Matlin received a grant of 6,230 stock options on August 13, 2026 under the Clene Inc. Amended 2020 Stock Plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clene Inc. director David J. Matlin received a grant of 6,230 stock options on August 13, 2026 under the Clene Inc. Amended 2020 Stock Plan. The options have an exercise price of $4.19 per share, vest immediately upon grant, and are exercisable into 6,230 shares of common stock until August 12, 2036. Following this award, Matlin holds 6,230 stock options directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | stock option F1 | 6,230 | $0.00 | $0.00 |
Footnotes (1)
- F1. This option was granted on August 13, 2026 as an option for 6,230 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.
Key Figures
Key Terms
stock option financial
exercise price financial
vest immediately upon grant financial
Amended 2020 Stock Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Clene Inc. (CLNN) report for David J. Matlin?
What is the exercise price of the new Clene (CLNN) stock options granted to David J. Matlin?
When do David J. Matlin’s newly granted Clene (CLNN) stock options vest and expire?
How many Clene (CLNN) stock options does David J. Matlin hold after this Form 4 transaction?
Was the Clene (CLNN) option grant to David J. Matlin made under a specific equity plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.